Trade Mark Journal No.2026/036 4 September 2026
WO0000001932748 (35)
Office of origin: United States of America
Date of International Registration:24 June 2026
Date of designation in the UK:
24 June 2026

International priority date claimed: 3 February 2026
(United States of America)
(99631029)
- Class 35
- Healthcare management services, namely, providing administrative support services to physicians and healthcare providers who prescribe pharmaceutical preparations; business administration of patient reimbursement programs for pharmaceuticals; business administration of patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient.
Mallinckrodt Pharmaceuticals Ireland Limited
Representative: Camille M. Miller, 1650 Market Street,, Suite 2800, Philadelphia PA 19103, UNITED STATES OF AMERICA